Corient Private Wealth LP purchased a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 93,001 shares of the company’s stock, valued at approximately $2,153,000.
Other hedge funds also recently modified their holdings of the company. Parallax Volatility Advisers L.P. purchased a new stake in shares of Bath & Body Works in the second quarter worth approximately $987,000. Bank of America Corp DE purchased a new position in Bath & Body Works during the second quarter valued at approximately $62,249,000. Caisse de depot et placement du Quebec acquired a new position in Bath & Body Works in the 2nd quarter valued at approximately $3,719,000. Man Group plc acquired a new position in Bath & Body Works in the 2nd quarter valued at approximately $22,670,000. Finally, Jupiter Topco LLC purchased a new stake in Bath & Body Works in the 2nd quarter worth approximately $1,830,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.
Bath & Body Works Stock Performance
Shares of BBWI opened at $18.52 on Thursday. The firm has a market cap of $3.73 billion, a PE ratio of 4.82, a PEG ratio of 1.93 and a beta of 1.38. The firm’s 50 day moving average price is $20.18 and its 200 day moving average price is $19.87. Bath & Body Works, Inc. has a twelve month low of $14.27 and a twelve month high of $32.32.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Friday, August 21st will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.3%. Bath & Body Works’s dividend payout ratio is currently 20.83%.
Wall Street Analyst Weigh In
BBWI has been the subject of a number of research reports. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. UBS Group cut their price objective on Bath & Body Works from $19.00 to $17.00 and set a “neutral” rating for the company in a report on Thursday, August 27th. Jefferies Financial Group lifted their price objective on Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Weiss Ratings upgraded Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 9th. Finally, Piper Sandler began coverage on Bath & Body Works in a research report on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price on the stock. Four equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $22.29.
Check Out Our Latest Research Report on Bath & Body Works
Bath & Body Works Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Stories
- Five stocks we like better than Bath & Body Works
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
